Loading…

A novel fluorometric enzyme analysis method for Hunter syndrome using dried blood spots

Mucopolysaccharidosis type II (MPS II) or Hunter syndrome is a lysosomal storage disease caused by deficiency of iduronate-2-sulfatase (IDS). A convenient single-step fluorometric microplate enzyme assay has been developed and validated for clinical diagnosis of MPS II using dried blood spots (DBS)....

Full description

Saved in:
Bibliographic Details
Published in:Molecular genetics and metabolism 2012-03, Vol.105 (3), p.519-521
Main Authors: Tolun, Adviye A., Graham, Carrie, Shi, Qun, Sista, Ramakrishna S., Wang, Tong, Eckhardt, Allen E., Pamula, Vamsee K., Millington, David S., Bali, Deeksha S.
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Mucopolysaccharidosis type II (MPS II) or Hunter syndrome is a lysosomal storage disease caused by deficiency of iduronate-2-sulfatase (IDS). A convenient single-step fluorometric microplate enzyme assay has been developed and validated for clinical diagnosis of MPS II using dried blood spots (DBS). The assay compared well with a recently reported digital microfluidic method, from which it was adapted. Results show that this DBS assay is robust and reproducible using both technologies. ► Single-step fluorometric DBS based diagnostic method to diagnose Hunter disease. ► Results compared well with recently reported digital microfluidic method. ► DBS fluorometric assay is robust, non-invasive and reproducible.
ISSN:1096-7192
1096-7206
DOI:10.1016/j.ymgme.2011.12.011